Revumenib (SNDX-5613): a promising menin inhibitor for the management of relapsed and refractory acute myeloid leukaemia (AML)

Ann Med Surg (Lond). 2024 Mar 18;86(5):2379-2381. doi: 10.1097/MS9.0000000000001888. eCollection 2024 May.

Authors

Harmla Hussain¹, Syeda Mahrukh Fatima Zaidi¹, Syed Mohammad Hasan¹, Aelia Sarv Jahan¹, Burhanuddin Sohail Rangwala², Hussain Sohail Rangwala², Mirha Ali², Asma Ahmed Farah³

Affiliations

¹ Department of Surgery Unit 6, Dr. Ruth K. M. Pfau, Civil Hospital Karachi.
² Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
³ Department of Medicine, East Africa University, Boosaaso, Somalia.

No abstract available

Publication types

Editorial